A detailed history of Patten Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Patten Group, Inc. holds 2,960 shares of LLY stock, worth $2.51 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
2,960
Previous 3,025 2.15%
Holding current value
$2.51 Million
Previous $2.74 Million 4.24%
% of portfolio
0.6%
Previous 0.66%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$772.14 - $960.02 $50,189 - $62,401
-65 Reduced 2.15%
2,960 $2.62 Million
Q2 2024

Jul 25, 2024

BUY
$724.87 - $909.04 $117,428 - $147,264
162 Added 5.66%
3,025 $2.74 Million
Q1 2024

Apr 17, 2024

SELL
$592.2 - $792.28 $4,737 - $6,338
-8 Reduced 0.28%
2,863 $2.23 Million
Q4 2023

Jan 10, 2024

SELL
$525.19 - $619.13 $38,864 - $45,815
-74 Reduced 2.51%
2,871 $1.67 Million
Q3 2023

Oct 12, 2023

SELL
$434.7 - $599.3 $34,341 - $47,344
-79 Reduced 2.61%
2,945 $1.58 Million
Q2 2023

Jul 26, 2023

SELL
$350.74 - $468.98 $4,559 - $6,096
-13 Reduced 0.43%
3,024 $1.42 Million
Q1 2023

Apr 06, 2023

BUY
$310.63 - $364.82 $310 - $364
1 Added 0.03%
3,037 $1.04 Million
Q4 2022

Feb 10, 2023

SELL
$321.55 - $374.67 $5,144 - $5,994
-16 Reduced 0.52%
3,036 $1.11 Million
Q3 2022

Oct 13, 2022

BUY
$296.48 - $337.87 $46,843 - $53,383
158 Added 5.46%
3,052 $997,000
Q2 2022

Jul 18, 2022

SELL
$278.73 - $327.27 $9,198 - $10,799
-33 Reduced 1.13%
2,894 $949,000
Q1 2022

Apr 28, 2022

SELL
$234.69 - $291.66 $12,438 - $15,457
-53 Reduced 1.78%
2,927 $838,000
Q4 2021

Jan 20, 2022

BUY
$224.85 - $279.04 $28,555 - $35,438
127 Added 4.45%
2,980 $823,000
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $177,501 - $218,440
801 Added 39.04%
2,853 $659,000
Q2 2021

Aug 03, 2021

BUY
$180.55 - $233.54 $34,304 - $44,372
190 Added 10.2%
2,052 $471,000
Q1 2021

Apr 23, 2021

BUY
$164.32 - $212.72 $50,117 - $64,879
305 Added 19.59%
1,862 $348,000
Q2 2020

Jul 20, 2020

SELL
$136.42 - $164.18 $38,606 - $46,462
-283 Reduced 15.38%
1,557 $256,000
Q1 2020

Apr 16, 2020

BUY
$119.05 - $147.35 $28,572 - $35,364
240 Added 15.0%
1,840 $255,000
Q4 2019

Jan 14, 2020

BUY
$106.92 - $132.43 $171,072 - $211,888
1,600 New
1,600 $210,000
Q2 2019

Jul 11, 2019

SELL
$110.79 - $129.32 $188,343 - $219,844
-1,700 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$105.9 - $118.64 $21,180 - $23,728
200 Added 13.33%
1,700 $197,000
Q3 2017

Dec 13, 2017

BUY
$77.07 - $85.54 $106,587 - $118,301
1,383 Added 1182.05%
1,500 $128,000
Q3 2017

Nov 14, 2017

SELL
$77.07 - $85.54 $106,587 - $118,301
-1,383 Reduced 92.2%
117 $128,000
Q2 2017

Aug 14, 2017

BUY
N/A
1,500
1,500 $123,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $805B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Patten Group, Inc. Portfolio

Follow Patten Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patten Group, Inc. with notifications on news.